BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 106951)

  • 1. Medulloblastoma: treatment results and effect on normal tissues.
    Cumberlin RL; Luk KH; Wara WM; Sheline GE; Wilson CB
    Cancer; 1979 Mar; 43(3):1014-20. PubMed ID: 106951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation.
    Saran FH; Driever PH; Thilmann C; Mose S; Wilson P; Sharpe G; Adamietz IA; Böttcher HD
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):959-67. PubMed ID: 9869216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy.
    Wara WM; Le QT; Sneed PK; Larson DA; Prados MD; Levin VA; Edwards MS; Weil MD
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):551-6. PubMed ID: 7928485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undernutrition and Pubertal Timing in Female Survivors of Medulloblastoma and Other Embryonal Tumors.
    Zhu J; Feldman HA; Chordas C; Wassner AJ; Manley PE; Cohen LE
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3650-9. PubMed ID: 32706870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medulloblastoma--treatment and prognosis. A study of seventeen cases in ten years.
    Probert JC; Lederman M; Bagshaw MA
    Calif Med; 1973 Jan; 118(1):14-7. PubMed ID: 4631185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management.
    Kopelson G; Linggood RM; Kleinman GM
    Cancer; 1983 Jan; 51(2):312-9. PubMed ID: 6401586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of radiation therapy for medulloblastoma].
    Shibamoto Y; Abe M; Tsutsui K; Ono K; Takahashi M
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2491-8. PubMed ID: 2614186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medulloblastoma. A review of the LDS hospital experience.
    Brown RC; Gunderson L; Plenk HP
    Cancer; 1977 Jul; 40(1):56-60. PubMed ID: 880571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the therapeutic ratio of craniospinal irradiation in medulloblastoma.
    Maor MH; Fields RS; Hogstrom KR; van Eys J
    Int J Radiat Oncol Biol Phys; 1985 Apr; 11(4):687-97. PubMed ID: 3980265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
    Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
    J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival.
    Hughes EN; Shillito J; Sallan SE; Loeffler JS; Cassady JR; Tarbell NJ
    Cancer; 1988 May; 61(10):1992-8. PubMed ID: 3129177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses.
    Sethi RV; Giantsoudi D; Raiford M; Malhi I; Niemierko A; Rapalino O; Caruso P; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):655-63. PubMed ID: 24521681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality control of low dose craniospinal irradiation for low risk medulloblastoma.
    Benk V; Bouhnik H; Raquin MA; Kalifa C; Habrand JL
    Br J Radiol; 1995 Sep; 68(813):1009-13. PubMed ID: 7496681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor.
    Massimino M; Gandola L; Collini P; Seregni E; Marchianò A; Serra A; Pignoli E; Spreafico F; Pallotti F; Terenziani M; Biassoni V; Bombardieri E; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):404-10. PubMed ID: 17601681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
    Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C
    Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma.
    Packer RJ; Sutton LN; Goldwein JW; Perilongo G; Bunin G; Ryan J; Cohen BH; D'Angio G; Kramer ED; Zimmerman RA
    J Neurosurg; 1991 Mar; 74(3):433-40. PubMed ID: 1847194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
    Oyharcabal-Bourden V; Kalifa C; Gentet JC; Frappaz D; Edan C; Chastagner P; Sariban E; Pagnier A; Babin A; Pichon F; Neuenschwander S; Vinchon M; Bours D; Mosseri V; Le Gales C; Ruchoux M; Carrie C; Doz F
    J Clin Oncol; 2005 Jul; 23(21):4726-34. PubMed ID: 16034048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.
    Douglas JG; Barker JL; Ellenbogen RG; Geyer JR
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1161-4. PubMed ID: 15001259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.